The role of the interaction of the AT1 and AT2 angiotensin II receptors in the ontogenesis of hypertension: a study in "Ren-2" transgenic rats
Public support
Provider
Ministry of Health
Programme
Branch programm of research of the Ministry of Health
Call for proposals
VaV pro Ministerstvo zdravotnictví 2 (SMZ02005NR)
Main participants
—
Contest type
VS - Public tender
Contract ID
NR8550-3/2005
Alternative language
Project name in Czech
Úloha interakce AT1 a AT2 receptorů pro angiotenzin II v ontogenezi hypertenze, studie na "Ren-2" transgenních potkanech
Annotation in Czech
Bude studována úloha interakce AT1 a AT2 receptorů pro angiotenzin II v ontogenezi hypertenze na modelu Ren-2 transgenních potkanů.
Scientific branches
R&D category
NV - Nonindustrial research (Applied research excluded Industrial research)
CEP classification - main branch
FA - Cardiovascular diseases including cardio-surgery
CEP - secondary branch
FR - Pharmacology and apothecary chemistry
CEP - another secondary branch
FP - Other medical fields
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
30104 - Pharmacology and pharmacy<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30201 - Cardiac and Cardiovascular systems<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30501 - Forensic science<br>30502 - Other medical science
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
The result represents the extension of knowledge about etiopatogenesis of hypertension and also verification of the new therapeutic principle.
Solution timeline
Realization period - beginning
Jan 1, 2005
Realization period - end
Dec 31, 2007
Project status
U - Finished project
Latest support payment
Mar 1, 2007
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP08-MZ0-NR-U/03:1
Data delivery date
Sep 16, 2008
Finance
Total approved costs
4,838 thou. CZK
Public financial support
4,728 thou. CZK
Other public sources
110 thou. CZK
Non public and foreign sources
0 thou. CZK